Reference Section

Kjell Öberg, MD, PhD, is Professor of Endocrine Oncology at the Medical Faculty of Uppsala University, Sweden. He is founder and Head of the Endocrine Oncology Clinic and a specialist in endocrinology and internal medicine. He has more than 20 years of experience in the field of neuroendocrine tumors. Between 1986 and 1992 he was Clinical Associate Director of the Ludwig Institute for Cancer Research. From 1998 to 2002 he was Chairman of the Department of Medical Sciences at the Medical Faculty of Uppsala University. He is currently Dean of the Medical Faculty, and has been since July 2002. Dr Öberg is co-ordinator of the European Neuroendocrine Tumour Network (ENET) and also Chairman of the Nordic Endocrine Tumour Network. He has pioneered the treatment of carcinoid tumor patients with interferon (IFN) and somatostatin analogs and has developed assays for tumor markers such as chromogranin A and radiological procedures, such as specialised PET scannings. He described genetic deletion in multiple endocrine neoplasia type 1 (MEN-1) for the first time in 1988. In 1991 Dr Öberg received the European Interferon Research Award. He has given hundreds of lectures at international meetings and has published more than 400 papers within his research field. In June 2003, Dr Öberg received the award of ‘Eminent Scientist Year 2003’ from the International Research Promotion Council (IRPC) and World Scientist Forum. In November 2004 he received the European Gold Medal in Endocrinology from the English Endocrine Society.